Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies directed against programmed death-1 (PD-1)

Antibodies directed against programmed death-1 (PD-1)

US Patent 11155624 · Granted Oct 26, 2021

Estimated economic value: $13,123,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions comprising anti-NRP2 antibodies2025
Antibodies directed against interleukin 36 receptor (IL-36R)2025
Anti-IL-18BP antibodies2025
Method of treating an interleukin-11-associated or -mediated fibrotic disease or2025
Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies2024
Compositions and methods comprising anti-NRP2 antibodies2024
Method of treating autoimmune disease with antibodies against IL-332024
Therapeutic compositions comprising anti-NRP2 antibodies2023
Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)2023
Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)2023
Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)2023
FcRn antibodies and methods of use thereof2023